australian patients for thai cosmetic clinics

You already pay for international patients

This is not a market that needs convincing to spend. When I verified the channel in July 2026, Wansiri Hospital was running roughly 290 active Meta ads, including creative aimed squarely at overseas patients, and Rattinan was active too. Mid-tier cosmetic hospitals demonstrably buy paid social at volume.

The problem is not the spend. It is what the spend leaves behind. Rented reach stops the day the budget stops. The audience data sits inside the platform, the creative expires, and nothing compounds in your name. Ten years of Meta ads can leave a hospital no more visible to an Australian searching from Sydney than it was on day one.

Word of mouth is real, and it is a ceiling

The sector's honest answer about where international patients come from is referrals. Yanhee Hospital's own about-us page states that "75% of Yanhee's international patients are either former patients or word-of-mouth referrals from previous patients." Academic studies of thai hospital marketing repeatedly reach the same finding: word of mouth is the dominant channel.

Referrals are earned, and they deserve respect. But they follow existing patient communities. If your current international base skews regional, referrals will keep it that way, because Australians who have never heard of you cannot recommend you. Opening the Australian market takes a deliberate channel: visibility where Australians search, content that answers their questions in their own English, and reviews they can find and trust.

Two rulebooks apply to every campaign

For cosmetic medicine the compliance stakes run higher than anywhere else, and they run in both directions.

On the Thai side, the Medical Facility Act requires DoHSS approval of medical facility advertisements before publication. Approval takes 10 to 30 working days with fees per creative, and penalties include THB 10,000 per day for ignoring a takedown order. Enforcement is real: a criminal case over a misleading stem-cell campaign convicted the advertising agency alongside the clinic. And from 3 July 2026, updated Medical Council rules require cosmetic-enhancement ads to display the practitioner's real first name, surname and medical licence number, with nicknames permitted only alongside the real name in identical colour, style and size. Social media is in scope, and sanctions run to licence suspension.

On the Australian side, there are firm constraints on what advertising may say to Australian consumers about therapeutic services and goods. I work inside Australian healthcare advertising rules every week for my anchor clients, so this is not a rulebook I am learning on your time.

Holding both halves is the point. A Bangkok agency does not know the Australian side, and an Australian generalist does not know the Thai side. My working standard is creative built for pre-approval the first time, written to clear both rulebooks before it is submitted, so the 10-to-30-day cycle happens once rather than three times.

Owned channel versus rented flow

Everything I build accrues to you: your rankings in Australian search and AI answers, your review architecture, your content answering Australian patients' questions, and tracking in your own accounts reported against enquiries and booked patients. If we ever part ways, you keep all of it.

MediSiam takes no commissions, ever, and never charges a percentage of treatment value. The fee is known, published and finite. The asset is permanent.

Start with the free report

The Australia Visibility Report shows what Australian patients actually see when they look for your hospital or clinic: Google Australia, AI answers, review platforms and the competitors who currently hold that ground. It is written, free, and needs no access to your systems.

Request yours at /visibility-report.